News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
Verdict Confirms CELLECTIS SA’s Fight To Protect Its Intellectual Property
November 12, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Paris, November 12, 2009 – Cellectis S.A. (Alternext: ALCLS), the French genome engineering specialist, has announced that the Paris Tribunal de grande instance has dismissed the lawsuit filed by Genoway in January 2009.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Europe
MORE ON THIS TOPIC
Government
Trump’s Tax Law Restores Orphan Drug Exemptions, Cuts Medicaid, Threatens 340B Program and Gives PBMs a Pass
July 8, 2025
·
3 min read
·
Tristan Manalac
Legal
Medical Groups Sue RFK Jr. Over ‘Baseless and Uninformed’ Changes to COVID-19 Vaccine Policy
July 8, 2025
·
2 min read
·
Tristan Manalac
Layoffs
HHS Cuts and Rehires by the Numbers: What We Know About Kennedy’s Overhaul
July 7, 2025
·
3 min read
·
Tristan Manalac
Mergers & acquisitions
Sage’s Search for Lifeline Ran Into Defiant Biogen CEO
July 3, 2025
·
3 min read
·
Annalee Armstrong
